GET THE APP

Hypertensive Nephropathy: Huangqi Injection Treatment | 95786

医療経済とアウトカム研究: オープンアクセス

ISSN - 2471-268X

概要

Hypertensive Nephropathy: Huangqi Injection Treatment

Wiatt Iluka

The extract of Astragalus membranaceus (Fisch.) Bunge is known as uangqi injection (HQI), and it is frequently used in China to treat a wide range of illnesses. It is expected to have a significant role in hypertensive nephropathy adjuvant therapy.

HQI and antihypertensive medications should be evaluated for their effectiveness in treating hypertensive nephropathy. When combined with antihypertensive medications, HQI is more effective than antihypertensive medications alone at improving associated indexes in patients with hypertensive nephropathy, and a moderate dose of HQI may be more beneficial. The methodology's poor quality and the study's small sample size mean that further rigorous randomised controlled trials are required to corroborate the findings.

免責事項: この要約は人工知能ツールを使用して翻訳されたものであり、まだレビューまたは検証されていません。